Journalartikel

Zolmitriptan inhibits neurogenic inflammation and pain during electrical stimulation in human skin


AutorenlisteDoering, K.; Best, C.; Birklein, F.; Kraemer, H. H.

Jahr der Veröffentlichung2015

Seiten966-972

ZeitschriftEuropean Journal of Pain

Bandnummer19

Heftnummer7

ISSN1090-3801

eISSN1532-2149

DOI Linkhttps://doi.org/10.1002/ejp.622

VerlagWiley


Abstract

BackgroundTriptans are agonists to 5-HT 1B/D/F receptors, which are present on nociceptive neurons not only within but also beyond the trigeminal system. The aim of this study was to investigate whether zolmitriptan interacts with peptidergic nociceptive afferents in human skin.

MethodsTwenty participants (13 women, median age: 25; interquartile range: 23-26 years) entered the randomized, double-blind, cross-over study. Electrically induced neurogenic flare and pain was assessed after either placebo or zolmitriptan on the ventral thigh. Mechanical pain thresholds were investigated at baseline and after electrical stimulation at the stimulation site.

ResultsThe size of the neurogenic flare (F=10.9; p=0.002) as well as electrically induced pain were significantly reduced by zolmitriptan (F=4.46; p=0.041). Moreover, electrically induced pinprick hyperalgesia was significantly decreased by zolmitriptan compared with placebo (F=6.243; p=0.017).

ConclusionsTriptans may have effects outside of the trigeminal system and reduce electrically evoked neurogenic inflammation and pain in human skin.




Zitierstile

Harvard-ZitierstilDoering, K., Best, C., Birklein, F. and Kraemer, H. (2015) Zolmitriptan inhibits neurogenic inflammation and pain during electrical stimulation in human skin, European Journal of Pain, 19(7), pp. 966-972. https://doi.org/10.1002/ejp.622

APA-ZitierstilDoering, K., Best, C., Birklein, F., & Kraemer, H. (2015). Zolmitriptan inhibits neurogenic inflammation and pain during electrical stimulation in human skin. European Journal of Pain. 19(7), 966-972. https://doi.org/10.1002/ejp.622



Schlagwörter


ANTIMIGRAINE ACTIONFLARENEUROPATHIC PAINNOCICEPTORSREFLEXESSUMATRIPTAN


Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-21-05 um 18:35